The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
Ori Biotech and CTMC partner to accelerate novel cell therapy delivery
London, UK, and Houston, TX, US, September 13, 2022 - Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing technologies, and the...
MD Anderson and Obsidian Therapeutics announce FDA clearance of IND application for novel TIL therapy OBX-115
HOUSTON and CAMBRIDGE, Mass. ― The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug...
CTMC, Invectys, and MD Anderson announce strategic collaboration for CAR T cell therapy development
HOUSTON – Invectys, Inc., the University of Texas MD Anderson Cancer Center, and the Cell Therapy Manufacturing Center (CTMC), a joint venture...
Recent News
Expert tips to choose the right CDMO for your biotech company
By Jules Adam Outsourcing to a contract development and manufacturing organization (CDMO) is a critical step for many biotech companies aiming...
3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization
By Amy Hay, CBO, CTMC Cell and gene therapies have introduced unprecedented therapeutic possibilities into the clinical landscape, but their...
Emerging Treatments for Cancer e-book
Access article: BioPharm International
TILs’ Tomorrow Bringing More Cancers Under Immune Control
Four leading companies prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities...
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies.
Preferred Partner Network (PPN) members will become Centers of Excellence for the IRO® platform combining best-in-class technology with...
Emerging Therapies in Oncology: Tumor-Infiltrating Lymphocytes
Author(s): Susan Haigney BioPharm International® spoke with Jason Bock, founder and CEO of CTMC, to find out about the newest cancer treatments,...
2025 pharma predictions
From manufacturing to supply chain strategies, here’s how drug manufacturers are looking at the year ahead. Andrea Corona access article: Pharma...
Patient-focused manufacturing models for personalised therapies
Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, CTMC, is challenging the...
New cell therapy model accelerates cancer treatment development
Article Link: https://www.drugtargetreview.com/article/155900/new-cell-therapy-model-accelerates-cancer-treatment-development/